{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:04:30Z","timestamp":1777460670853,"version":"3.51.4"},"reference-count":15,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1253\/circj.cj-17-0229","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T03:58:52Z","timestamp":1492487932000},"page":"888-890","source":"Crossref","is-referenced-by-count":19,"title":["Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms"],"prefix":"10.1253","volume":"81","author":[{"given":"Deborah A.","family":"Howatt","sequence":"first","affiliation":[{"name":"Saha Cardiovascular Research Center, University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Dajee","sequence":"additional","affiliation":[{"name":"Cardio-Metabolic Diseases, Merck Research Laboratories, Cardiovascular Research Center, Merck & Co., Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Xie","sequence":"additional","affiliation":[{"name":"Saha Cardiovascular Research Center, University of Kentucky"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Department of Cardiology, Second Affiliated Hospital, Zhejiang University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Moorleghen","sequence":"additional","affiliation":[{"name":"Saha Cardiovascular Research Center, University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra L.","family":"Rateri","sequence":"additional","affiliation":[{"name":"Saha Cardiovascular Research Center, University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Balakrishnan","sequence":"additional","affiliation":[{"name":"Saha Cardiovascular Research Center, University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valdeci","family":"Da Cunha","sequence":"additional","affiliation":[{"name":"Cardio-Metabolic Diseases, Merck Research Laboratories, Cardiovascular Research Center, Merck & Co., Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas G.","family":"Johns","sequence":"additional","affiliation":[{"name":"Cardio-Metabolic Diseases, Merck Research Laboratories, Cardiovascular Research Center, Merck & Co., Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Gutstein","sequence":"additional","affiliation":[{"name":"Cardio-Metabolic Diseases, Merck Research Laboratories, Cardiovascular Research Center, Merck & Co., Inc."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Daugherty","sequence":"additional","affiliation":[{"name":"Saha Cardiovascular Research Center, University of Kentucky"},{"name":"Department of Physiology, University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Lu","sequence":"additional","affiliation":[{"name":"Saha Cardiovascular Research Center, University of Kentucky"},{"name":"Department of Physiology, University of Kentucky"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Du XJ, Hewitson TD, Nguyen MN, Samuel CS. Therapeutic effects of serelaxin in acute heart failure. <i>Circ J<\/i> 2014; 78: 542\u2013552.","DOI":"10.1253\/circj.CJ-14-0014"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ahmad N, Wang W, Nair R, Kapila S. Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: Induction of MMP-9 involves the PI3K, ERK, Akt and PKC-zeta pathways. <i>Mol Cell Endocrinol<\/i> 2012; 363: 46\u201361.","DOI":"10.1016\/j.mce.2012.07.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Urbonavicius S, Urbonaviciene G, Honore B, Henneberg EW, Vorum H, Lindholt JS. Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture: A systematic review. <i>Eur J Vasc Endovasc Surg<\/i> 2008; 36: 273\u2013280; discussion 281\u2013282.","DOI":"10.1016\/j.ejvs.2008.05.009"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. <i>J Clin Invest<\/i> 2000; 105: 1641\u20131649.","DOI":"10.1172\/JCI8931"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. <i>J Clin Invest<\/i> 2002; 110: 625\u2013632.","DOI":"10.1172\/JCI0215334"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lu H, Aikawa M. Many faces of matrix metalloproteinases in aortic aneurysms. <i>Arterioscler Thromb Vasc Biol<\/i> 2015; 35: 752\u2013754.","DOI":"10.1161\/ATVBAHA.115.305401"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Liu J, Lu H, Howatt DA, Balakrishnan A, Moorleghen JJ, Sorci-Thomas M, et al. Associations of apoAI and apoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice. <i>Arterioscler Thromb Vasc Biol<\/i> 2015; 35: 1826\u20131834.","DOI":"10.1161\/ATVBAHA.115.305482"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. <i>J Clin Invest<\/i> 2000; 105: 1605\u20131612.","DOI":"10.1172\/JCI7818"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dominska K, Ochedalski T, Kowalska K, Matysiak-Burzynska ZE, Pluciennik E, Piastowska-Ciesielska AW. A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line. <i>J Physiol Biochem<\/i> 2016; 72: 381\u2013392.","DOI":"10.1007\/s13105-016-0489-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Haase N, Rugor J, Przybyl L, Qadri F, Muller DN, Dechend R. Relaxin does not improve Angiotensin II-induced target-organ damage. <i>PLoS One<\/i> 2014; 9: e93743.","DOI":"10.1371\/journal.pone.0093743"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Uchida HA, Poduri A, Subramanian V, Cassis LA, Daugherty A. Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms. <i>Arterioscler Thromb Vasc Biol<\/i> 2011; 31: 2845\u20132852.","DOI":"10.1161\/ATVBAHA.111.234997"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, et al. MMP-9\/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. <i>Cell<\/i> 1998; 93: 411\u2013422.","DOI":"10.1016\/S0092-8674(00)81169-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration arterial remodeling and geometrical. <i>Circulation Research<\/i> 2002; 91: 852\u2013859.","DOI":"10.1161\/01.RES.0000041036.86977.14"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Deguchi JO, Huang H, Libby P, Aikawa E, Whittaker P, Sylvan J, et al. Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II. <i>Lab Invest<\/i> 2009; 89: 315\u2013326.","DOI":"10.1038\/labinvest.2008.167"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Carmo M, Colombo L, Bruno A, Corsi FR, Roncoroni L, Cuttin MS, et al. Alteration of elastin, collagen and their cross-links in abdominal aortic aneurysms. <i>Eur J Vasc Endovasc Surg<\/i> 2002; 23: 543\u2013549.","DOI":"10.1053\/ejvs.2002.1620"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/6\/81_CJ-17-0229\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T14:58:09Z","timestamp":1498402689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/6\/81_CJ-17-0229\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0229","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}